Literature DB >> 4186729

Association between foeto-maternal bleeding and hypertension in pregnancy.

P Jones, A McNay, W Walker.   

Abstract

A blind prospective survey of foeto-maternal bleeding in 200 primiparous pregnancies was carried out in an investigation of a possible association between foeto-maternal bleeding and hypertension in pregnancy. Evidence of foeto-maternal bleeding was found in 61% of 36 hypertensive pregnancies, and in 51% of 160 normotensive pregnancies, a difference which is not statistically significant.Significant differences between the hypertensive and the normotensive groups were found when foeto-maternal bleeding was related to gestation. In pregnancies that became hypertensive more foetal cells were found in the maternal circulation before week 36 than in normotensive pregnancies. In patients with oedema of the abdominal wall during pregnancy the incidence of foeto-maternal bleeding was significantly increased.These findings seem to explain why pre-eclamptic toxaemia is a significant predisposing factor in women who later develop Rh antibodies. It is recommended that anti-D gammaglobulin should be offered to all Rh-negative women with Rh-positive infants following a hypertensive pregnancy. Consideration should also be given to the question of administering anti-D gammaglobulin during Rh-negative hypertensive pregnancies if this procedure is proved to be both safe to mother and foetus and effective.The results provide contributory evidence that the placental vascular changes in toxaemic pregnancies precede the clinical signs and are not the result of hypertension.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4186729      PMCID: PMC1984611          DOI: 10.1136/bmj.3.5673.738

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  20 in total

1.  [Demonstration of fetal hemoglobin in erythrocytes of a blood smear].

Authors:  E KLEIHAUER; H BRAUN; K BETKE
Journal:  Klin Wochenschr       Date:  1957-06-15

2.  Anaemia from bleeding of the fetus into the mother's circulation.

Authors:  B CHOWN
Journal:  Lancet       Date:  1954-06-12       Impact factor: 79.321

3.  The origin and significance of macroscopic intervillous coagulation hematomas (red infarcts) of the human placenta.

Authors:  C T JAVERT; C REISS
Journal:  Surg Gynecol Obstet       Date:  1952-03

4.  Obstetric determinants of rhesus sensitisation.

Authors:  E G Knox
Journal:  Lancet       Date:  1968-03-02       Impact factor: 79.321

5.  Foetal-maternal transfusion and rhesus sensitization.

Authors:  R Pilkington; E G Knox; J K Russell; W Walker
Journal:  J Obstet Gynaecol Br Commonw       Date:  1966-12

6.  Fetal erythrocytes in the maternal circulation.

Authors:  D C McLarey; S A Fish
Journal:  Am J Obstet Gynecol       Date:  1966-07-15       Impact factor: 8.661

7.  Transplacental haemorrhage.

Authors:  J C Woodrow; R Finn
Journal:  Br J Haematol       Date:  1966-05       Impact factor: 6.998

8.  Assessment of size of small volume feto-maternal bleeds. A new method of quantification of the Kleihauer technique.

Authors:  P Jones
Journal:  Br Med J       Date:  1969-04-12

Review 9.  Life-span of the fetal red blood cell.

Authors:  H A Pearson
Journal:  J Pediatr       Date:  1967-02       Impact factor: 4.406

10.  Incidence of maternal Rh immunization by ABO compatible and incompatible pregnancies.

Authors:  W Q Ascari; P Levine; W Pollack
Journal:  Br Med J       Date:  1969-02-15
View more
  4 in total

1.  Relation between maternal and infant blood folate activities.

Authors:  M J Landon; A Oxley
Journal:  Arch Dis Child       Date:  1971-12       Impact factor: 3.791

2.  Rhesus sensitization and abortion.

Authors:  P Jones
Journal:  Br Med J       Date:  1969-11-22

3.  Fibrinolytic systems in eclampsia.

Authors:  P Jones
Journal:  Br Med J       Date:  1971-04-24

Review 4.  Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum.

Authors:  Sinuhe Hahn; Paul Hasler; Lenka Vokalova; Shane Vontelin van Breda; Nandor Gabor Than; Irene Mathilde Hoesli; Olav Lapaire; Simona W Rossi
Journal:  Front Immunol       Date:  2019-03-29       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.